These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 301392)

  • 1. Absorption, distribution and metabolic fate of 2,3-dihydro-9H-isoxazolo-[3,2-b]quinazolin-9-one (W2429).
    Edelson J; Douglas JF; Ludwig BJ
    Arzneimittelforschung; 1977; 27(4):789-93. PubMed ID: 301392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The disposition of 3-methyl-2,3-dihydro-9H-isoxazolo[3,2-b]-quinazolin-9-one (W-2451).
    Kucharczyk N; Ballard F; Yang J; Myers G; Sofia RD
    Arch Int Pharmacodyn Ther; 1979 Jun; 239(2):180-94. PubMed ID: 114130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absorption, distribution, and metabolic fate of 7-chloro-3,3a-dihydro-2-methyl-2H,9H-isoxazolo-(3,2-b)(1,3)-benzoxazin-9-one in rats, dogs, and humans.
    Edelson J; Douglas JF; Ludwig BJ; Schuster EB; Shahinian S
    J Pharm Sci; 1975 Aug; 64(8):1316-21. PubMed ID: 1097636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicological investigation of 2,3-dihydro-9H-isoxazolo[3,2-b]quinazolin-9-one (W-2429). Acute and subacute toxicity in mice, rats and dogs.
    Banerjee BN; Sofia RD; Ivins NJ; Ludwig BJ
    Arzneimittelforschung; 1977; 27(4):793-801. PubMed ID: 301393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2,3-Dihydro-9H-isoxazolo[3,2-b]quinazolin-9-ones and 3,4-dihydro-(1,2)-oxazino [3,2-b]quinazolin-10(2H)-ones.
    Reisner DB; Ludwig BJ; Simon E; Dejneka T; Sofia RD
    Arzneimittelforschung; 1977; 27(4):766-70. PubMed ID: 301391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological properties of 2,3-dihydro-9H-isoxazolo [3,2-b] quinazolin-9-one (W-2429. Part 1: Analgesic, antipyretic and antiedema activity.
    Sofia RD; Diamantis W; Ludwig BJ
    Arzneimittelforschung; 1977; 27(4):770-82. PubMed ID: 17418
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative metabolism of fenclorac in rat, dog, monkey, and man.
    DeLong AF; Smyth RD; Polk A; Nayak RK; Martin G; Douglas GH; Reavey-Cantiwell NH
    Drug Metab Dispos; 1977; 5(2):122-31. PubMed ID: 15804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological properties of 2,3-dihydro-9H-isoxazolo[3,2-b]-quinazolin-9-one (W-2429. Part 2: General pharmacological investigation.
    Sofia RD; Diamantis W; Gordon R; Edelson J; Ludwig BJ
    Arzneimittelforschung; 1977; 27(4):782-9. PubMed ID: 405977
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetics of 4-acetylaminophenylacetic acid. 1st communication: absorption, distribution, metabolism and excretion in mice, rats, dogs and monkeys after single administration of 14C-labeled compound.
    Sugihara K; Morino A; Nomura A; Iida S; Sugiyama M
    Arzneimittelforschung; 1990 Jul; 40(7):800-5. PubMed ID: 2222556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absorption, distribution and excretion of 3-(sulfamoyl[14C]methyl)-1,2-benziosoxazole (AD-810) in Rats, Dogs and Monkeys and of AD-810 in Men.
    Matsumoto K; Miyazaki H; Fujii T; Kagemoto A; Maeda T; Hashimoto M
    Arzneimittelforschung; 1983; 33(7):961-8. PubMed ID: 6138046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
    Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
    Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 4th communication: absorption, metabolism, excretion and plasma protein binding in various animals and man.
    Mizojiri K; Okabe H; Sugeno K; Misaki A; Ito M; Kominami G; Esumi Y; Takaichi M; Harada T; Seki H; Inaba A
    Arzneimittelforschung; 1997 Mar; 47(3):259-69. PubMed ID: 9105544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The biotransformation of fluproquazone in man and several animal species.
    Orwig BA; Dugger HA; Bhuta SI; Talbot KC; Schwarz HJ
    Arzneimittelforschung; 1981; 31(5a):904-11. PubMed ID: 6973984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The metabolic fate of 14C-ximoprofen in rats, baboons and humans.
    Mayo BC; Chasseaud LF; Hawkins DR; Taylor IW; Legeai J
    Xenobiotica; 1990 Mar; 20(3):233-46. PubMed ID: 2336835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition of remoxipride in different species. Species differences in metabolism.
    Widman M; Nilsson LB; Bryske B; Lundström J
    Arzneimittelforschung; 1993 Mar; 43(3):287-97. PubMed ID: 8489555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of nimodipine. I. Communication: absorption, concentration in plasma and excretion after single administration of [14C]nimodipine in rat, dog and monkey.
    Maruhn D; Siefert HM; Weber H; Rämsch K; Suwelack D
    Arzneimittelforschung; 1985; 35(12):1781-6. PubMed ID: 4096729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacokinetics of nitrendipine. I. Absorption, plasma concentrations, and excretion after single administration of [14C]nitrendipine to rats and dogs.
    Krause HP; Ahr HJ; Beermann D; Siefert HM; Suwelack D; Weber H
    Arzneimittelforschung; 1988 Nov; 38(11):1593-9. PubMed ID: 3214442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism and pharmacokinetics of 4-(p-chlorophenylthio)butanol (W-2719) in the rat and dog.
    Kucharczyk N; Edelson J; Sofia RD; Ludwig BJ; Shahinian S; Schuster E; Ballard FH; Yang J; Myers G
    Arzneimittelforschung; 1979; 29(10):1550-6. PubMed ID: 583221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
    Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
    Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.